Tellacq SKr105 million acquisition of 75% stake in Nordic Biosite

15/5/2018

Private acquisition

Value:

SKr 105 million

Dollar value:

$ 10.933 million

Status:

Announced

Date:

15/5/2018

Overview:

Healthcare investment group Tellacq has agreed to acquire a 75% stake in Nordic Biosite for SKr105 million.

Prin Shasiharan - Researcher

Jurisdiction:

Sweden

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:

Cederquist

Party: Tellacq (Acquirer)

Lawyer: Lars Bärnheim (moved in-house)

Setterwalls

Party: Nordic Biosite (Seller)

Related deals